The project is developing a new approach to removing blood clots that aims to overcome key limitations of existing mechanical thrombectomy technologies. Current treatments typically rely on mechanical devices that capture or aspirate the clot by applying radial force or suction. While effective in many cases, these approaches can sometimes lead to incomplete clot removal, fragmentation of the clot, or difficulty reaching smaller and more delicate blood vessels.
The technology developed in this project introduces a different mechanism for clot removal. Instead of relying primarily on mechanical gripping or suction, the device uses controlled electric fields to create an attractive interaction between the catheter and the clot. This interaction occurs along the length of the clot and enables the device to attach to it more uniformly. By distributing the attachment force across the clot rather than concentrating it at a single point, the technology aims to reduce the risk of clot fragmentation and improve the chances of removing the clot in a single attempt.
This concept represents a significant step beyond current thrombectomy approaches because it combines minimally invasive catheter technology with a novel physical mechanism for clot capture. The design is intended to minimize contact with the vessel wall while maintaining a strong and controlled interaction with the clot. If validated clinically, this approach could allow physicians to treat clots located in smaller or more fragile vessels that are difficult to access with existing devices.
The results achieved so far demonstrate the technical feasibility of this concept. Engineering optimization has led to a miniaturized catheter design suitable for navigating complex vascular anatomy, while laboratory and animal testing has confirmed that the device can generate strong attachment forces with different types of clots. These results support the potential of the technology to provide a more controlled and reliable method of clot retrieval.
Looking forward, further clinical evaluation will be required to confirm the safety and effectiveness of the technology in patients. Successful demonstration in clinical studies would enable the technology to progress toward regulatory approval and eventual integration into clinical practice.
The potential impact of this innovation is significant. By improving the effectiveness and reliability of clot removal procedures, the technology could help physicians restore blood flow more quickly and reduce complications associated with incomplete clot retrieval or distal embolization. This may translate into improved recovery outcomes for patients suffering from stroke and other clot-related conditions.
